Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 3;14(4):197.
doi: 10.3390/jfb14040197.

Lutein Encapsulated in PLGA-Phospholipid Nano-Carrier Effectively Mitigates Cytokines by Inhibiting Tumor Necrosis Factor TNF-α and Nuclear Factor NF- κ B in Mice Retina

Affiliations

Lutein Encapsulated in PLGA-Phospholipid Nano-Carrier Effectively Mitigates Cytokines by Inhibiting Tumor Necrosis Factor TNF-α and Nuclear Factor NF- κ B in Mice Retina

Ranganathan Arunkumar et al. J Funct Biomater. .

Abstract

Lutein, a photo- and thermo-labile macular pigment, prevents the retina from suffering ocular inflammation with its antioxidant and anti-inflammatory activity. However, its biological activity is poor due to poor solubility and bioavailability. Therefore, we developed a PLGA NCs (+PL), (poly (lactic-co-glycolic acid) nanocarrier with phospholipid) to improve the biological availability and bioefficacy of lutein in the retina of lipopolysaccharide (LPS)-induced lutein-devoid (LD) mice. The effect of lutein-loaded NCs with/without PL was studied in comparison with micellar lutein. The induction of inflammation by LPS significantly increased the production of nitrites in the LPS-induced group, revealing higher levels of nitric oxide (NO) in the serum (760%) and retina (891%) compared to the control group. Malondialdehyde (MDA) levels in the serum (93%) and retina (205%) of the LPS-induced group were higher compared to the control group. LPS induction resulted in increased protein carbonyls in the serum (481%) and retina (487%) of the LPS group compared to the control group. Further, to conclude, lutein-PLGA NCs (+PL) effectively down-regulated inflammatory complications in the retina.

Keywords: LPS; PLGA; anti-inflammation; antioxidant; carotenoids; lutein; nanocarrier; phospholipids; retina.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Effect of lutein-PLGA NCs (+PL)/(−PL) and micellar lutein on NO levels in serum (A) and retina (B) of LD mice previously induced with LPS. Groups: 1 = control, 2 = LPS, 3 = micellar lutein, 4 = lutein-PLGA NCs (−PL), and 5 = lutein-PLGA NCs (+PL) gavaged for 15 days. Values are mean ± SD (n = 6) and bars not sharing a similar superscript are significantly different (p < 0.05) among the groups.
Figure 2
Figure 2
Effect of lutein-PLGA NCs (+PL)/(−PL) and micellar lutein on MDA levels in serum (A) and retina (B) of LD mice previously induced with LPS. Groups: 1 = control, 2 = LPS, 3 = micellar lutein, 4 = lutein-PLGA NCs (−PL), and 5 = lutein-PLGA NCs (+PL) intubated for 15 days. Values are mean ± SD (n = 6) and bars not sharing a similar superscript are significantly different (p < 0.05) among the groups.
Figure 3
Figure 3
Effect of lutein-PLGA NCs (+PL)/(−PL) and micellar lutein on protein carbonyl levels in serum (A) and retina (B) of LD mice previously induced with LPS. Groups: 1 = control, 2 = LPS, 3 = micellar lutein, 4 = lutein-PLGA NCs (−PL), and 5 = lutein-PLGA NCs (+PL) intubated for 15 days. Values are mean ± SD (n = 6) and bars not sharing a similar superscript are significantly different (p < 0.05) among the groups.
Figure 4
Figure 4
Effect of lutein-PLGA NCs (+PL)/(−PL) and micellar lutein on TNF-α (A), MCP-1 (B), IL-6 (C), IL-1B (D), and PGE2 (E) levels in serum of LD mice induced with LPS. Groups: 1—Control, 2—LPS, 3—Micellar lutein, 4—Lutein-PLGA NCs (−PL) and 5—Lutein-PLGA NCs (+PL). Values are mean ± SD (n = 5) and bars not sharing similar superscript are significantly different (p < 0.05).
Figure 5
Figure 5
Protein expression pattern of iNOS (A) and COX-2 (C) in retina of LPS-induced LD mice. Lane 1—control, 2—LPS, 3—lutein-PLGA NCs (+PL), 4—lutein-PLGA NCs (-PL), 5—lutein. Relative values of iNOS (B) and COX-2 (D) over the control. Bars not sharing similar superscript are significantly different (p < 0.05).
Figure 6
Figure 6
Effect of lutein-PLGA NCs (+PL)/(−PL) and micellar lutein on NF-κB p65 subunit activation in retina of LPS-induced LD mice. 1 = control, 2 = LPS, 3 = micellar lutein, 4 = lutein-PLGA NCs (−PL), and 5 = lutein-PLGA NCs (+PL). Mean ± SD (n = 5) and bars not sharing similar superscript are significantly different (p < 0.05).
Figure 7
Figure 7
Bioavailability of lutein from lutein-PLGA NCs (+PL)/(−PL) and micellar lutein in the serum and retina of LPS-induced LD mice. Mean ± SD (n = 5) and bars not sharing similar superscript are significantly different (p < 0.05).

References

    1. Kauppinen A., Paterno J.J., Blasiak J., Salminen A., Kaarniranta K. Inflammation and Its Role in Age-Related Macular Degeneration. Cell Mol. Life Sci. 2016;73:1765–1786. doi: 10.1007/s00018-016-2147-8. - DOI - PMC - PubMed
    1. Rosenbaum J.T., McDevitt H.O., Guss R.B., Egbert P.R. Endotoxin-Induced Uveitis in Rats as a Model for Human Disease. Nature. 1980;286:611–613. doi: 10.1038/286611a0. - DOI - PubMed
    1. Fang H., Pengal R.A., Cao X., Ganesan L.P., Wewers M.D., Marsh C.B., Tridandapani S. Lipopolysaccharide-Induced Macrophage Inflammatory Response Is Regulated by SHIP. J. Immunol. 2004;173:360–366. doi: 10.4049/jimmunol.173.1.360. - DOI - PubMed
    1. Skrzypczak-Wiercioch A., Sałat K. Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use. Molecules. 2022;27:5481. doi: 10.3390/molecules27175481. - DOI - PMC - PubMed
    1. Hwang D., Kang M.-J., Jo M.J., Seo Y.B., Park N.G., Kim G.-D. Anti-Inflammatory Activity of β-Thymosin Peptide Derived from Pacific Oyster (Crassostrea gigas) on NO and PGE2 Production by Down-Regulating NF-ΚB in LPS-Induced RAW264.7 Macrophage Cells. Mar. Drugs. 2019;17:129. doi: 10.3390/md17020129. - DOI - PMC - PubMed